We are live on ! Find out more
PWP

Private Wealth Partners Portfolio holdings

AUM $1.3B
1-Year Est. Return 26.2%
This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+26.2%
3 Year Est. Return
+92.82%
5 Year Est. Return
+128.24%
10 Year Est. Return
+552.95%
AUM
$642M
AUM Growth
-$7.14M
Cap. Flow
-$12M
Cap. Flow %
-1.88%
Top 10 Hldgs %
46.71%
Holding
142
New
8
Increased
39
Reduced
47
Closed
19

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$4.86M
2
ZTS icon
Zoetis
ZTS
+$2.49M
3
BABA icon
Alibaba
BABA
+$2.06M
4
GS icon
Goldman Sachs
GS
+$1.75M
5
AXP icon
American Express
AXP
+$1.34M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.88M
2
FNV icon
Franco-Nevada
FNV
+$5.44M
3
SCHW
Charles Schwab
SCHW
+$3.67M
4
EOG icon
EOG Resources
EOG
+$3.34M
5
FRC
First Republic Bank
FRC
+$1.54M

Sector Composition

Rank Sector Weight
1 Financials 21.34%
2 Healthcare 20.87%
3 Technology 18.4%
4 Communication Services 14.03%
5 Consumer Discretionary 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAC icon
76
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
$665K 0.1%
44,358
+5,000
+13% +$74.4K
PG icon
77
Procter & Gamble
PG
$343B
$662K 0.1%
5,320
+3,034
+133% +$359K
MLM icon
78
Martin Marietta Materials
MLM
$33.6B
$637K 0.1%
2,325
QCOM icon
79
Qualcomm
QCOM
$176B
$621K 0.1%
8,145
-10,900
-57% -$820K
PHYS icon
80
Sprott Physical Gold
PHYS
$14.6B
$591K 0.09%
50,000
UNP icon
81
Union Pacific
UNP
$183B
$575K 0.09%
3,551
LUV icon
82
Southwest Airlines
LUV
$22.1B
$540K 0.08%
10,000
TROW icon
83
T. Rowe Price
TROW
$25B
$457K 0.07%
4,000
DEO icon
84
Diageo
DEO
$46.2B
$415K 0.06%
2,540
-1,000
-28% -$167K
BMY icon
85
Bristol-Myers Squibb
BMY
$127B
$411K 0.06%
8,110
+2,200
+37% +$103K
MMP
86
DELISTED
Magellan Midstream Partners, L.P.
MMP
$409K 0.06%
6,169
KLAC icon
87
KLA
KLAC
$275B
$392K 0.06%
24,600
BDX icon
88
Becton Dickinson
BDX
$43.1B
$379K 0.06%
1,538
VGT icon
89
Vanguard Information Technology ETF
VGT
$139B
$373K 0.06%
13,832
MO icon
90
Altria Group
MO
$122B
$368K 0.06%
+8,998
New +$414K
WFC icon
91
Wells Fargo
WFC
$261B
$366K 0.06%
7,250
+1,264
+21% +$59.5K
VTR icon
92
Ventas
VTR
$48.9B
$353K 0.05%
4,830
+330
+7% +$23.4K
IWF icon
93
iShares Russell 1000 Growth ETF
IWF
$122B
$334K 0.05%
8,380
SLB icon
94
SLB Ltd
SLB
$77.8B
$330K 0.05%
9,650
-4,600
-32% -$168K
IWD icon
95
iShares Russell 1000 Value ETF
IWD
$82B
$323K 0.05%
2,516
HON icon
96
Honeywell
HON
$77.1B
$309K 0.05%
1,941
+96
+5% +$15.3K
SIX
97
DELISTED
Six Flags Entertainment Corp.
SIX
$305K 0.05%
6,000
PANW icon
98
Palo Alto Networks
PANW
$264B
$299K 0.05%
8,808
WMT icon
99
Walmart Inc
WMT
$871B
$284K 0.04%
7,176
+477
+7% +$18K
NFLX icon
100
Netflix
NFLX
$292B
$281K 0.04%
10,500
-3,000
-22% -$93.9K

Similar funds

Private Wealth Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Private Wealth Partners held 142 positions worth $642M, down 1.1% from $650M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Private Wealth Partners's Q3 2019 filing shows 8 new, 39 increased, 47 reduced and 19 closed positions. Its largest new stake was Principia Biopharma Inc. Common Stock: 24,000 shares worth $678K. The largest sale was Pfizer, an estimated $6.88M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.

  • Private Wealth Partners's largest Q3 2019 buy was Principia Biopharma Inc. Common Stock: 24,000 shares worth $678K.
  • Private Wealth Partners added most to AT&T in Q3 2019, an estimated $4.86M increase.
  • Private Wealth Partners's biggest Q3 2019 reduction was Pfizer, cutting an estimated $6.88M.
  • Private Wealth Partners fully exited Franco-Nevada in Q3 2019, selling an estimated $5.44M.
  • Private Wealth Partners's ten largest holdings make up 47% of its $642M portfolio in Q3 2019.
  • Private Wealth Partners opened 8 new positions and closed 19 in Q3 2019.
  • Private Wealth Partners's portfolio value fell 1.1% quarter-over-quarter to $642M.

Based on Private Wealth Partners's 13F filing for Q3 2019, filed 12 Nov 2019.